Doxycycline attenuates cancer cell growth by suppressing nlrp3-mediated inflammation

HIGHLIGHTS

• who: Mohammad Alsaadi and collaborators from the Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia have published the paper: Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation, in the Journal: Pharmaceuticals 2021, 14, 852. of /2021/
• what: The authors selected a prostate cancer cell line, PC3, and lung cancer-derived cell line, A549, to investigate the impact of doxycycline on NLRP3 activation.
• how: Data were analyzed using one-way ANOVA model with Tukey's post hoc tests. Data were analyzed using Luminex 200 analyzer with MasterPlex CT control . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.